Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: Effects of dosage and timing

British Journal of Cancer

Volumn 81, Issue 1, 1999, Pages 62-68

  Collet, J P ^a,b   Sharpe, C ^a,b   Belzile, E ^a   Boivin, J F ^a,b   Hanley, J ^b   Abenhalm, L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Case control studies; Colorectal cancer; Epidemiology; Non steroidal anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; DICLOFENAC; DIFLUNISAL; FENOPROFEN; FLOCTAFENINE; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; MEFENAMIC ACID; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; SULINDAC; TIAPROFENIC ACID; TOLMETIN; ZOMEPIRAC;

ADULT; ARTICLE; CANADA; CANCER INCIDENCE; CASE CONTROL STUDY; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER;

AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RISK FACTORS; SASKATCHEWAN;

EID: 0032850948     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690651     Document Type: Article

References (30)

1. Berkel HJ, Holcombe RF, Middlebrooks M and Kannan K (1996) Nonsteroidal antiinflammalory drugs and colorectal cancer. Epidemiol Rev 18: 205-217
2. Birkenmfeld S, Zaltsman YA, Krispin M, Zakut H, Zor U and Kohen F (1987) Antitumor effects of inhibitors of arachidonic acid cascade on experimentally induced intestinal tumors. Dis Colon Rectum 30: 43-46
3. Brenner H and Gefeller O (1993) Use of the positive predictive value to correct for disease misclassification in epidemiologic studies. Am J Epidemiol 138: 1007-1015
4. Breslow NE and Day NE (1980) Statistical Methods in Cancer Research. Volume I - The Analysis of Csae - control Studies. International Agency for Research on Cancer: Lyon
5. Carson JL, Strom B, Morse ML, West SL, Soper KA, Stolley PD, et al. (1987) The relative gastrointestinal toxicity of the nonsteroidal anti-inflammatory drugs. Arch Int Med 147: 1054-1059
6. Krogh CME (ed) (1995) Compendium of Pharmaceuticals and Specialties, 30th edition. Canadian Pharmaceutical Association: Ottawa
7. Gann PH, Manson JE, Glynn RJ, Burling JE and Hennekens CH (1993) Low-dose aspirin and incidence of colorectal tumors in a randomized clinical trial. J Natl Cancer Inst 85: 1220-1224
8. Giovannucci E, Colditz GA, Stampfer MJ, Hunter D, Rosner BA. Willett WC et al (1994a) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women. J Natl Cancer Inst 86: 192-199
9. Giovannucci F, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Kearney J, et al, (1994b) A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. men. J Natl Cancer Inst 86: 183-191
10. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A and Willett WC (1994c) Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241-246
11. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al (1995) Aspirin and the risk of colorectal cancer in women. N Eng J Med 333: 609-614
12. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, et al (1993) Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 85: 307-311
13. Lundhohn K, Gelin J, Hyltander A, Lönnroth C, Sandström K and Svaninger G (1994) Anti inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res 54: 5602-5606
14. MacMahon B and Trichopoulos D (1996) Epidemiology. Principles and Methods. Second Edition. Little, Brown: Boston
15. Marshall JR, Priore R, Graham S and Brasure J (1981) On the distortion of risk estimates in multiple exposure level case - control studies. Am J Epidemiol 113: 464-473
16. Miettinen OS (1985) Theoritical Epidemiology. Principles of occurrence research in medicine. Delmar: Albany
17. Newcomb PA and Storer BE (1995) Postmenopausal hormone use and risk of large-bowel cancer. J Natl Cancer Inst 87: 1067-1071
18. Paganini-Hill A, Chao A, Ross RK and Henderson BE (1989) Aspirin use and chronic diseases: a cohort study of the elderly. Br Med J 299: 1241-1250
19. Parkin DM, Whelan SL, Ferlay J, Raymond L and Young J (eds.) (1997) Cancer Incidence in Five Continents. Volume VII. International Agency for Research on Cancer: Lyon
20. Peleg H, Lubin MF, Cotsonis GA, Clark WS and Wilcox CM (1996) Long-term use of nonsteroidal anttinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia. Dig Dis Sci 41: 1319-1326
21. Pollard M and Luckert PH (1981) Effect of indomethacin on intestinal tumors induced in rats by the acetate derivate of dimethylnitrosamine. Science 214: 558-559
22. Potter JD, Slattery ML, Bostick RM and Gapstur SM (1993) Colon cancer: a review of the epidemiology. Epidemiol Rev 15: 499-545
23. Rawson NSB, D'Arey C, Blackburn JL, Bowen RC, Wallace SM, Downey W, et al (1992) Epidemiologic research using linked computerized health care datafiles in Saskatchewan, Canada. Technical Report Series. In Report #2. Psychiatric Pharmacoepidemiology Research Consortium: Saskatoon.
24. Risch HA and Howe GR (1994) Menopausal hormone usage and breast cancer in Saskatchewan: a record-linkage study. Am J Epidemiol 139: 670-683
25. Rosenberg L, Palmer JR, Zauber AG, Warshauer E, Stolley PD and Shapiro S (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83: 355-358
26. Rothman KJ and Greenland S (1998) Modern Epidemiology, 2nd edition. Lippincott Raven: Philadelphia
27. Rothman KJ (1981) Induction and latent periods. Am J Epidemiol 114: 253-259
28. SAS Institute (1992) SAS/STAT software: changes and enhancements, release 6.07. In: SAS Technical Report P-229. SAS Institute: Cary, NC
29. Schreinemachers DM and Everson RB (1994) Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology 5: 138-146
30. Thun MJ, Namboodiri MM and Health CW (1991) Aspirin use and reduced risk of fatal colon cancer. N Eng J Med 325: 1593-1596